drugset / Trial / NCT00635609

Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate

NCT00635609

Phase 4 Completed 93 enrolled Warner Chilcott
RandomizedParallel-groupOpen-labelTreatment

Summary

Randomized, multi-center, open label, active-comparator study to compare the efficacy and tolerability of Doryx Delayed Release Tablets to doxycycline hyclate in patients with moderate to severe acne vulgaris.

Timeline

Start
2008-03
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule 100 mg Oral
Subject Doxycycline Small molecule 150 mg Oral

Indications